View of Deciphering the therapeutic potential of bergenin in breast cancer: In silico insights into HSP90AA1 and HRAS interaction mediated inhibition of PI3K-Akt and MAPK signaling pathway

Return to Article Details Deciphering the therapeutic potential of bergenin in breast cancer: In silico insights into HSP90AA1 and HRAS interaction mediated inhibition of PI3K-Akt and MAPK signaling pathway Download Download PDF